aldosterone has been researched along with Deficiency, Vitamin D in 12 studies
Excerpt | Relevance | Reference |
---|---|---|
"Thirty-three consecutive patients with essential hypertension and hypovitaminosis D underwent therapy with cholecalciferol 50 000 IU/week orally for 8 weeks." | 3.83 | Cholecalciferol treatment downregulates renin-angiotensin system and improves endothelial function in essential hypertensive patients with hypovitaminosid D. ( Bacca, A; Bernini, G; Bruno, RM; Carrara, D; Duranti, E; Ghiadoni, L; Taddei, S, 2016) |
"Valsartan treatment did not affect plasma PTH, although treatment reduced diastolic blood pressure (P = ." | 2.87 | Effects of treatment with an angiotensin 2 receptor blocker and/or vitamin D3 on parathyroid hormone and aldosterone: A randomized, placebo-controlled trial. ( Bislev, LS; Bjerregaard Pedersen, E; Langagergaard Rødbro, L; Nørgaard Bech, J; Rejnmark, L; Rolighed, L; Sikjaer, T, 2018) |
"Vitamin D deficiency is associated with hypertension." | 1.46 | Nocturnal diastolic blood pressure decline is associated with higher 25-hydroxyvitamin D level and standing plasma renin activity in a hypertensive population. ( Gao, M; Li, H; Liu, H; Xu, X; Zhang, J; Zhang, M, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (8.33) | 29.6817 |
2010's | 8 (66.67) | 24.3611 |
2020's | 3 (25.00) | 2.80 |
Authors | Studies |
---|---|
Han, L | 1 |
Xu, XJ | 1 |
Zhang, JS | 1 |
Liu, HM | 1 |
Renke, G | 1 |
Starling-Soares, B | 1 |
Baesso, T | 1 |
Petronio, R | 1 |
Aguiar, D | 1 |
Paes, R | 1 |
Simpson, CA | 1 |
Zhang, JH | 1 |
Vanderschueren, D | 1 |
Fu, L | 1 |
Pennestri, TC | 1 |
Bouillon, R | 1 |
Cole, DEC | 1 |
Carpenter, TO | 1 |
Zhang, M | 1 |
Xu, X | 1 |
Liu, H | 1 |
Li, H | 1 |
Zhang, J | 1 |
Gao, M | 1 |
Bislev, LS | 1 |
Langagergaard Rødbro, L | 1 |
Nørgaard Bech, J | 1 |
Bjerregaard Pedersen, E | 1 |
Rolighed, L | 1 |
Sikjaer, T | 1 |
Rejnmark, L | 1 |
Fernández-Juárez, G | 1 |
Luño, J | 1 |
Barrio, V | 1 |
de Vinuesa, SG | 1 |
Praga, M | 1 |
Goicoechea, M | 1 |
Lahera, V | 1 |
Casas, L | 1 |
Oliva, J | 1 |
Morgado-Pascual, JL | 1 |
Rayego-Mateos, S | 1 |
Valdivielso, JM | 1 |
Ortiz, A | 1 |
Egido, J | 1 |
Ruiz-Ortega, M | 1 |
Grübler, MR | 1 |
Gaksch, M | 1 |
Kienreich, K | 1 |
Verheyen, N | 1 |
Schmid, J | 1 |
Ó Hartaigh, BW | 1 |
Richtig, G | 1 |
Scharnagl, H | 1 |
Meinitzer, A | 1 |
Pieske, B | 1 |
Fahrleitner-Pammer, A | 1 |
März, W | 1 |
Tomaschitz, A | 1 |
Pilz, S | 1 |
Zhang, W | 1 |
Zheng, X | 1 |
Wang, Y | 1 |
Xiao, H | 1 |
Carrara, D | 2 |
Bruno, RM | 1 |
Bacca, A | 2 |
Taddei, S | 2 |
Duranti, E | 2 |
Ghiadoni, L | 2 |
Bernini, G | 2 |
Bernini, M | 1 |
Rugani, I | 1 |
Virdis, A | 1 |
Nguyen, DN | 1 |
Nguyen, LT | 1 |
Luong, Kv | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Randomized, Controlled Trial of Vitamin D Supplementation in Infants and Children: Effects of Vitamin D Dose and Genotype of the Binding Protein[NCT01050387] | 193 participants (Actual) | Interventional | 2010-01-31 | Completed | |||
Styrian Vitamin D Hypertension Trial: A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Effects of Vitamin D Supplementation on Systolic Ambulatory Blood Pressure in Vitamin D Deficient Hypertensive Patients[NCT02136771] | Phase 4 | 200 participants (Actual) | Interventional | 2011-06-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for aldosterone and Deficiency, Vitamin D
Article | Year |
---|---|
Effects of Vitamin D on Cardiovascular Risk and Oxidative Stress.
Topics: Aldosterone; Calcitriol; Calcium; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Heart | 2023 |
3 trials available for aldosterone and Deficiency, Vitamin D
Article | Year |
---|---|
Effects of treatment with an angiotensin 2 receptor blocker and/or vitamin D3 on parathyroid hormone and aldosterone: A randomized, placebo-controlled trial.
Topics: Aged; Aldosterone; Angiotensin Receptor Antagonists; Blood Pressure; Cholecalciferol; Double-Blind M | 2018 |
25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.
Topics: Aged; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors | 2013 |
Effects of Vitamin D Supplementation on Plasma Aldosterone and Renin-A Randomized Placebo-Controlled Trial.
Topics: Aged; Aldosterone; Dietary Supplements; Double-Blind Method; Female; Humans; Hypertension; Male; Mid | 2016 |
8 other studies available for aldosterone and Deficiency, Vitamin D
Article | Year |
---|---|
Association between Vitamin D Deficiency and Levels of Renin and Angiotensin in Essential Hypertension.
Topics: Adult; Aldosterone; Angiotensins; Asian People; Blood Pressure; Essential Hypertension; Female; Huma | 2022 |
Relationship of Total and Free 25-Hydroxyvitamin D to Biomarkers and Metabolic Indices in Healthy Children.
Topics: Aldosterone; Biomarkers; Blood Glucose; Calcium; Child; Child, Preschool; Female; Glycated Hemoglobi | 2020 |
Nocturnal diastolic blood pressure decline is associated with higher 25-hydroxyvitamin D level and standing plasma renin activity in a hypertensive population.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aldosterone; Angiotensin II; Blood Pressure; Blood Pres | 2017 |
Paricalcitol Inhibits Aldosterone-Induced Proinflammatory Factors by Modulating Epidermal Growth Factor Receptor Pathway in Cultured Tubular Epithelial Cells.
Topics: ADAM Proteins; ADAM17 Protein; Aldosterone; Cell Line; Cell Proliferation; Epithelial Cells; ErbB Re | 2015 |
Vitamin D Deficiency as a Potential Marker of Benign Prostatic Hyperplasia.
Topics: Aged; Aldosterone; Biomarkers; Case-Control Studies; China; Humans; Male; Middle Aged; Organ Size; P | 2016 |
Cholecalciferol treatment downregulates renin-angiotensin system and improves endothelial function in essential hypertensive patients with hypovitaminosid D.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Cardiovascular Diseases; Cholecalciferol; Endoth | 2016 |
Cholecalciferol administration blunts the systemic renin-angiotensin system in essential hypertensives with hypovitaminosis D.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Cholecalciferol; Essential Hypertension; Female; Humans; H | 2014 |
Vitamin D deficiency in primary aldosteronism.
Topics: Aldosterone; Animals; Biomarkers; Follow-Up Studies; Humans; Hyperaldosteronism; Male; Middle Aged; | 2006 |